Delayed-Enhanced Cardiac MRI for Differentiation of Fabry's Disease from Symmetric Hypertrophic Cardiomyopathy

被引:85
作者
De Cobelli, Francesco [1 ,2 ]
Esposito, Antonio [1 ,2 ]
Belloni, Elena [1 ]
Pieroni, Maurizio [3 ]
Perseghin, Gianluca [4 ,5 ]
Chimenti, Cristina [6 ]
Frustaci, Andrea [6 ]
Del Maschio, Alessandro [1 ,2 ]
机构
[1] Ist Sci San Raffaele, Dept Radiol, I-20132 Milan, Italy
[2] Univ Vita Salute San Raffaele, I-20132 Milan, Italy
[3] Univ Cattolica Sacro Cuore, Dept Cardiol, I-00168 Rome, Italy
[4] Ist Sci San Raffaele, Sect Nutr & Metab, I-20132 Milan, Italy
[5] Univ Milan, Ctr Phys Exercise Hlth & Wellness, CDI Fac Exercise Sci, Milan, Italy
[6] Univ Roma La Sapienza, Dept Heart & Great Vessels Attilio Reale, Rome, Italy
关键词
cardiac MRI; delayed-enhanced MRI; Fabry's disease; hypertrophic cardiomyopathy; CARDIOVASCULAR MAGNETIC-RESONANCE; PREVALENCE; VARIANT;
D O I
10.2214/AJR.08.1201
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. Fabry's disease may be difficult to differentiate from symmetric hypertrophic cardiomyopathy. Our aim was to compare the myocardial location and distribution patterns of delayed enhancement between patients with Fabry's disease who are affected by symmetric myocardial hypertrophy and patients with symmetric hypertrophic cardiomyopathy in order to identify a specific sign to best differentiate the two diseases. CONCLUSION. Patients with Fabry's disease-related hypertrophy showed left ventricular (LV) delayed enhancement with a typical and consistently found pattern characterized by the involvement of the inferolateral basal or mid basal segments and a mesocardial distribution that spared the subendocardium. This pattern seems to be specific to Fabry's disease; in fact, patients with symmetric hypertrophic cardiomyopathy had variable locations and distributions of delayed enhancement. These observations may contribute to identifying Fabry's disease as a specific cause of symmetric hypertrophy.
引用
收藏
页码:W97 / W102
页数:6
相关论文
共 13 条
[1]   Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart - A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association [J].
Cerqueira, MD ;
Weissman, NJ ;
Dilsizian, V ;
Jacobs, AK ;
Kaul, S ;
Laskey, WK ;
Pennell, DJ ;
Rumberger, JA ;
Ryan, T ;
Verani, MS .
CIRCULATION, 2002, 105 (04) :539-542
[2]   Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy [J].
Chimenti, C ;
Pieroni, M ;
Morgante, E ;
Antuzzi, D ;
Russo, A ;
Russo, MA ;
Maseri, A ;
Frustaci, A .
CIRCULATION, 2004, 110 (09) :1047-1053
[3]   Safety and efficacy of recombinant human α-galactosidase a replacement therapy in Fabry's disease. [J].
Eng, CM ;
Guffon, N ;
Wilcox, WR ;
Germain, DP ;
Lee, P ;
Waldek, S ;
Caplan, L ;
Linthorst, GE ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :9-16
[4]   Brief report: Improvement in cardiac function in the cardiac variant of Fabry's disease with galactose-infusion therapy. [J].
Frustaci, A ;
Chimenti, C ;
Ricci, R ;
Natale, L ;
Russo, MA ;
Pieroni, M ;
Eng, CM ;
Desnick, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) :25-32
[5]   MRI characterization of myocardial tissue in patients with Fabry's disease [J].
Imbriaco, Massimo ;
Spinelli, Letizia ;
Cuocolo, Alberto ;
Maurea, Simone ;
Sica, Giacomo ;
Quarantelli, Mario ;
Pisani, Antonio ;
Liuzzi, Raffaele ;
Cianciaruso, Bruno ;
Sabbatini, Massimo ;
Salvatore, Marco .
AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (03) :850-853
[6]   Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies [J].
Mahrholdt, H ;
Wagner, A ;
Judd, RM ;
Sechtem, U ;
Kim, RJ .
EUROPEAN HEART JOURNAL, 2005, 26 (15) :1461-1474
[7]   The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease [J].
Moon, James C. ;
Sheppard, Mary ;
Reed, Emma ;
Lee, Phillip ;
Elliott, Perry M. ;
Pennell, Dudley J. .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2006, 8 (03) :479-482
[8]   The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy [J].
Moon, JCC ;
Reed, E ;
Sheppard, MN ;
Elkington, AG ;
Ho, SY ;
Burke, M ;
Petrou, M ;
Pennell, DJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2260-2264
[9]   Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium [J].
Moon, JCC ;
Sachdev, B ;
Elkington, AG ;
McKenna, WJ ;
Mehta, A ;
Pennell, DJ ;
Leed, PJ ;
Elliott, PM .
EUROPEAN HEART JOURNAL, 2003, 24 (23) :2151-2155
[10]   AN ATYPICAL VARIANT OF FABRYS-DISEASE IN MEN WITH LEFT-VENTRICULAR HYPERTROPHY [J].
NAKAO, S ;
TAKENAKA, T ;
MAEDA, M ;
KODAMA, C ;
TANAKA, A ;
TAHARA, M ;
YOSHIDA, A ;
KURIYAMA, M ;
HAYASHIBE, H ;
SAKURABA, H ;
TANAKA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (05) :288-293